Rapid nitric oxide–induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme
Open Access
- 15 October 2001
- journal article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 155 (2) , 271-278
- https://doi.org/10.1083/jcb.200107001
Abstract
Most of the effects of the signaling molecule nitric oxide (NO) are mediated by cGMP, which is synthesized by soluble guanylyl cyclase and degraded by phosphodiesterases. Here we show that in platelets and aortic tissue, NO led to a biphasic response characterized by a tremendous increase in cGMP (up to 100-fold) in less than 30 s and a rapid decline, reflecting the tightly controlled balance of guanylyl cyclase and phosphodiesterase activities. Inverse to the reported increase in sensitivity caused by NO shortage, concentrating NO attenuated the cGMP response in a concentration-dependent manner. We found that guanylyl cyclase remained fully activated during the entire course of the cGMP response; thus, desensitization was not due to a switched off guanylyl cyclase. However, when intact platelets were incubated with NO and then lysed, enhanced activity of phosphodiesterase type 5 was detected in the cytosol. Furthermore, this increase in cGMP degradation is paralleled by the phosphorylation of phosphodiesterase type 5 at Ser-92. Thus, our data suggest that NO-induced desensitization of the cGMP response is caused by the phosphorylation and subsequent activity increase of phosphodiesterase type 5.Keywords
This publication has 29 references indexed in Scilit:
- Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesteraseCellular Signalling, 2001
- Acute blood pressure effects of YC‐1‐induced activation of soluble guanylyl cyclase in normotensive and hypertensive ratsBritish Journal of Pharmacology, 2000
- Increased Nitrovasodilator Sensitivity in Endothelial Nitric Oxide Synthase Knockout MiceHypertension, 2000
- Analysis and Regulation of Vasodilator-stimulated Phosphoprotein Serine 239 Phosphorylation in Vitro and in Intact Cells Using a Phosphospecific Monoclonal AntibodyJournal of Biological Chemistry, 1998
- Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.Journal of Clinical Investigation, 1997
- Nitric Oxide Signaling in the Central Nervous SystemAnnual Review of Physiology, 1995
- Physiological concentrations of purines and pyrimidinesMolecular and Cellular Biochemistry, 1994
- Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cellsEuropean Journal of Biochemistry, 1992
- Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.Proceedings of the National Academy of Sciences, 1991
- Desensitization to nitroglycerin in vascular smooth muscle from rat and humanBiochemical Pharmacology, 1986